Table 2.
Prognostic effect of SHR and ABG on the risk of in-hospital adverse events
| Univariate logistic analysis | Multivariate logistic analysis | ROC analysis | |||
|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | AUC (95% CI) | |
| AKI | |||||
| ABG | 1.06 (1.02–1.10) | 0.001 | 1.02 (0.89–1.13) | 0.136 | 0.55 (0.48–0.61) |
| SHR | 3.59 (2.31–5.58) | < 0.001 | 3.18 (1.99–5.09) | < 0.001 | 0.64 (0.58–0.69)* |
| All-cause death | |||||
| ABG | 0.99 (0.93–1.05) | 0.824 | 1.00 (0.94–1.06) | 0.953 | 0.50 (0.42–0.57) |
| SHR | 1.97 (1.14–3.42) | 0.015 | 1.83 (1.03–3.23) | 0.038 | 0.59 (0.51–0.66) * |
| Cardiogenic shock | |||||
| ABG | 1.00 (0.95–1.04) | 0.760 | 0.97 (0.92–1.03) | 0.445 | 0.46 (0.39–0.52) |
| SHR | 2.24 (1.45–3.46) | 0.011 | 1.80 (1.12–2.87) | 0.014 | 0.60 (0.54–0.66) * |
OR was adjusted for age, gender, MI classification (STEMI or NSTEMI), PCI treatment (with or without) and peak TnI in the multivariate model. OR for per 1SD increase in ABG or SHR
ABG, admission blood glucose; SHR, stress hyperglycemia ratio; AKI, acute kidney injury; OR, odds ratio; CI, confidence interval
*Indicates a significant predictive value (p < 0.05) for the event